We retrospectively evaluated consecutive patients with symptomatic SBD who underwent enteroscopy over a 6-months period. Diagnostic yield, therapeutic success, total enteroscopy rate (TER), technical success (TS), total procedural time, depth of maximal insertion (DMI), and adverse events related to the NMSE procedure were noted.
Out of 61 patients (mean age of 45.67±15.37, 43 males) included for NMSE, 57 patients underwent successful enteroscopy with TS of 93.4%. The overall diagnostic yield was 65.5% (95% CI, 52.31 – 77.27) and 70.1% (95% CI, 56.60 – 81.57) in patient who underwent successful NMSE; TER was 60.6%: 31.1% by antegrade approach and 29.5% by combined antegrade and retrograde approach. DMI and procedural time was of 465 cm (100-650) and 40 minutes (25-60) by antegrade and 140 cm (50-200) and 35 minutes (30-60) by retrograde route. Lesions were classified as inflammatory (n=25), vascular (n=10) and mass (n=4). Biopsy specimens were obtained in 50.8% subjects and 23% patients underwent therapeutic procedures. No major adverse events were seen.
NMSE is a promising technology, showing high efficacy as a diagnostic and therapeutic tool in the management of otherwise difficult-to-treat SBD.
Copyright © 2020 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.